Altered synaptic function in Alzheimer's disease
- 27 June 2006
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 545 (1) , 11-21
- https://doi.org/10.1016/j.ejphar.2006.06.045
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Characterization of the neurotrophic interaction between nerve growth factor and secreted ?-amyloid precursor proteinJournal of Neuroscience Research, 2001
- Coordinated Expression of β‐Amyloid Precursor Protein and the Putative β‐Secretase BACE and α‐Secretase ADAM10 in Mouse and Human BrainJournal of Neurochemistry, 2000
- Decreased monoamine metabolites in frontotemporal dementia and Alzheimer’s diseaseNeurobiology of Aging, 1998
- Signal transduction by the neutrophin receptorsCurrent Opinion in Cell Biology, 1997
- Increased Activity‐Regulating and Neuroprotective Efficacy of α‐Secretase‐Derived Secreted Amyloid Precursor Protein Conferred by a C‐Terminal Heparin‐Binding DomainJournal of Neurochemistry, 1996
- Coupling of muscarinic receptors to GTP proteins in postmortem human brain — alterations in Alzheimer's diseaseNeuroscience Letters, 1993
- Diminished muscarinic receptor-stimulated [3H]-PIP2 hydrolysis in alzheimer's diseaseLife Sciences, 1993
- Animal and drug modelling for Alzheimer synaptic pathologyProgress in Neurobiology, 1992
- Alzheimer's DiseaseNew England Journal of Medicine, 1986
- Neurochemical Studies of Early-Onset Alzheimer's DiseaseNew England Journal of Medicine, 1985